Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises SEB in conjunction with co-operation with and investment in Leneo
Mandate

Vinge advises SEB in conjunction with co-operation with and investment in Leneo

June 20, 2022 IT, Telecommunications and Outsourcing M&A

Vinge has advised SEB in connection with the commencement of a strategic co-operation with and through SEB Venture Capital becoming a stakeholder in the Danish tech company, Leneo.

Leneo has developed a platform which assists companies to transfer to new business models, in which they sell a service instead of products, and where the product is included together with complementary services.

Vinge’s team primarily consisted of  Eva Fredrikson, Johan Winnerblad, Lisa Hörnqvist, Trine Osen Bergqvist and Carl Fredrik Wachtmeister.

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026